SAMHD1: A new gene for CLL

Blood

Volumn 123, Issue 7, 2014, Pages 951-952

  Rossi, Davide ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; DEOXYNUCLEOSIDE TRIPHOSPHATE TRIPHOSPHOHYDROLASE; DNA POLYMERASE; FLUDARABINE; HISTIDINE; NUCLEOSIDE DERIVATIVE; PROTEIN; SAMHD1 PROTEIN; SYNAPSIN I; UNCLASSIFIED DRUG;

AICARDI GOUTIERES SYNDROME; ALLELE; ANTIPROLIFERATIVE ACTIVITY; AUTOIMMUNE DISEASE; AUTOIMMUNE INFLAMMATORY ENCEPHALOPATHY; B LYMPHOCYTE; BRAIN DISEASE; CANCER IMMUNOTHERAPY; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL OBSERVATION; CLONAL EVOLUTION; CYTOTOXICITY; DNA DAMAGE; DNA SYNTHESIS; GENE; GENE ACTIVITY; GENE MUTATION; GENE SEQUENCE; GERM LINE; HUMAN; NOTE; PREVALENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; SAMHD1 GENE; TUMOR GENE; TUMOR SUPPRESSOR GENE; UNIPARENTAL DISOMY;

DNA DAMAGE; GERM-LINE MUTATION; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MONOMERIC GTP-BINDING PROTEINS;

EID: 84896990104     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-12-545384     Document Type: Note

References (10)

1. Clifford R, Louis T, Robbe P, et al. SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage. Blood 2014; 123(7):1021-1031.
2. Rossi D, Rasi S, Spina V, et al. Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia. Blood. 2013; 121(8):1403-1412.
3. Goldstone DC, Ennis-Adeniran V, Hedden JJ, et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature. 2011;480(7377): 379-382.
4. Franzolin E, Pontarin G, Rampazzo C, et al. The deoxynucleotide triphosphohydrolase SAMHD1 is a major regulator of DNA precursor pools in mammalian cells. Proc Natl Acad Sci USA. 2013;110(35):14272-14277.
5. Sze A, Olagnier D, Lin R, van Grevenynghe J, Hiscott J. SAMHD1 host restriction factor: a link with innate immune sensing of retrovirus infection. J Mol Biol. 2013; 425(24):4981-4994.
6. Rice GI, Bond J, Asipu A, et al. Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet. 2009;41(7):829-832.
7. Schuh A, Becq J, Humphray S, et al.Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns. Blood. 2012;120(20):4191-4196.
8. Landau DA, Carter SL, Stojanov P, et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell. 2013;152(4):714-726.
9. Crowther-Swanepoel D, Houlston RS. Genetic variation and risk of chronic lymphocytic leukaemia. Semin Cancer Biol. 2010;20(6):363-369.
10. Yoshio N, Kawai Y, Hori H, Ueda T. Resistance to 9-beta-D- arabinofuranosyl-2-fluoroadenine due to reduced incorporation into DNA from competition by excess deoxyadenosine triphosphate: implications for different sensitivities to nucleoside analogues. Int J Hematol. 2005;81(5): 405-412. (Pubitemid 40917683)